Henry S Friedman Selected Research

transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38)

1/2005	Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: case study.
10/2003	Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-alpha and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henry S Friedman Research Topics

Disease

106	Neoplasms (Cancer) 04/2022 - 01/2002
86	Glioma (Gliomas) 04/2024 - 01/2002
67	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 06/2002
35	Brain Neoplasms (Brain Tumor) 06/2021 - 01/2002
12	Melanoma (Melanoma, Malignant) 09/2011 - 01/2002
10	Fatigue 11/2023 - 10/2009
9	Medulloblastoma 01/2017 - 01/2002
8	Astrocytoma (Pilocytic Astrocytoma) 01/2019 - 01/2002
6	Hypoxia (Hypoxemia) 01/2014 - 01/2008
5	Diarrhea 04/2024 - 01/2004
5	Infections 01/2023 - 05/2002
5	Chronic Disease (Chronic Diseases) 04/2022 - 12/2014
5	Vomiting 05/2020 - 03/2006
4	Neutropenia 11/2023 - 01/2002
4	Nausea 05/2020 - 07/2014
4	Ependymoma 04/2015 - 01/2002
4	Central Nervous System Neoplasms 12/2013 - 05/2003
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 11/2023 - 10/2009
3	Poliomyelitis (Polio) 01/2023 - 11/2014
3	Disease Progression 04/2019 - 01/2002
3	Lymphopenia (Lymphocytopenia) 01/2012 - 03/2011
3	Hemorrhage 01/2012 - 10/2009
3	Rhabdomyosarcoma 11/2005 - 07/2002
3	Neuroblastoma 10/2004 - 09/2002
2	Hypertension (High Blood Pressure) 11/2023 - 10/2009
2	Inflammation (Inflammations) 01/2023 - 12/2018
2	Lymphoma (Lymphomas) 04/2020 - 08/2013
2	Headache (Headaches) 04/2015 - 03/2006
2	Exanthema (Rash) 04/2015 - 12/2010
2	Meningioma (Meningiomas) 08/2012 - 01/2012
2	Carcinogenesis 09/2011 - 01/2011

Drug/Important Bio-Agent (IBA)

44	Temozolomide (Temodar)FDA LinkGeneric 05/2020 - 09/2002
40	Bevacizumab (Avastin)FDA Link 11/2023 - 02/2007
31	Irinotecan (Camptosar)FDA LinkGeneric 11/2023 - 01/2002
22	ErbB Receptors (EGF Receptor)IBA 12/2014 - 01/2002
16	Monoclonal AntibodiesIBA 08/2012 - 03/2002
13	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2004
13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2014 - 09/2006
12	Carmustine (FIVB)FDA Link 08/2009 - 05/2002
11	epidermal growth factor receptor VIIIIBA 07/2018 - 01/2002
11	VaccinesIBA 01/2018 - 09/2003
10	Tyrosine Kinase InhibitorsIBA 07/2012 - 11/2002
10	O(6)-benzylguanineIBA 10/2009 - 05/2002
8	EnzymesIBA 04/2024 - 09/2004
8	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2014 - 11/2005
7	Alkylating AgentsIBA 08/2013 - 10/2002
7	Phosphotransferases (Kinase)IBA 06/2012 - 12/2004
6	Imatinib Mesylate (Gleevec)FDA Link 10/2012 - 12/2005
6	Peptides (Polypeptides)IBA 01/2012 - 01/2002
6	DNA (Deoxyribonucleic Acid)IBA 11/2010 - 09/2002
6	Alkyl and Aryl TransferasesIBA 02/2009 - 09/2002
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 04/2024 - 01/2018
5	7- chloro- 8- hydroxy- 1- (3'- iodophenyl)- 3- methyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepine (TISCH)IBA 06/2021 - 01/2007
5	AntigensIBA 01/2018 - 01/2002
5	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2012 - 12/2005
5	Melphalan (Alkeran)FDA LinkGeneric 05/2007 - 08/2004
4	AntiemeticsIBA 05/2020 - 07/2014
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2012 - 06/2002
4	TOR Serine-Threonine KinasesIBA 10/2011 - 01/2005
4	O(6)-Methylguanine-DNA MethyltransferaseIBA 12/2009 - 05/2002
4	Topoisomerase I InhibitorsIBA 10/2006 - 04/2004
4	Gefitinib (Iressa)FDA Link 02/2006 - 11/2002
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 04/2015
3	MethyltransferasesIBA 01/2019 - 10/2005
3	Etoposide (VP 16)FDA LinkGeneric 01/2017 - 04/2006
3	Palonosetron (Aloxi)FDA Link 01/2017 - 07/2014
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 06/2012 - 11/2002
3	Carboplatin (JM8)FDA LinkGeneric 03/2012 - 07/2002
3	CytokinesIBA 01/2012 - 10/2002
3	Everolimus FDA Link 10/2011 - 01/2005
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2011 - 01/2005
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2010 - 02/2006
3	Sirolimus (Rapamycin)FDA Link 01/2010 - 02/2006
3	Immunotoxins (Immunotoxin)IBA 06/2008 - 01/2005
3	laromustine (VNP40101M)IBA 02/2008 - 01/2007
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2007 - 01/2002
3	Glutathione (Reduced Glutathione)IBA 05/2007 - 08/2004
2	poliovirus receptorIBA 01/2023 - 12/2018
2	Ondansetron (Zofran)FDA LinkGeneric 05/2020 - 01/2017
2	A-factor (Streptomyces)IBA 01/2019 - 01/2011
2	Vorinostat FDA Link 04/2018 - 01/2018
2	AcidsIBA 01/2018 - 11/2007
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017 - 04/2015
2	Messenger RNA (mRNA)IBA 01/2017 - 12/2014
2	RNA (Ribonucleic Acid)IBA 04/2015 - 03/2015
2	Mitogen-Activated Protein KinasesIBA 12/2014 - 09/2007
2	Carbonic Anhydrase IXIBA 01/2014 - 01/2008
2	AEE 788 (AEE788)IBA 06/2012 - 01/2005
2	Anticonvulsants (Antiepileptic Drugs)IBA 06/2012 - 02/2006
2	Tyrosine (L-Tyrosine)FDA Link 06/2012 - 06/2007
2	TransferasesIBA 12/2011 - 04/2006

Therapy/Procedure

69	Therapeutics 04/2024 - 01/2002
38	Drug Therapy (Chemotherapy) 04/2022 - 01/2002
26	Radiotherapy 04/2022 - 01/2002
9	Immunotherapy 01/2023 - 05/2008
5	Salvage Therapy 03/2012 - 04/2006
4	Catheters 01/2023 - 02/2007
3	Radioimmunotherapy 05/2007 - 09/2005
2	Oncolytic Virotherapy 03/2016 - 11/2014
2	Drug Tapering 04/2013 - 01/2002